Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.340
-0.080 (-3.31%)
At close: Nov 14, 2025, 4:00 PM EST
2.310
-0.030 (-1.28%)
After-hours: Nov 14, 2025, 7:58 PM EST
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $17.56 million as of November 14, 2025. Its market cap has increased by 36.49% in one year.
Market Cap
17.56M
Enterprise Value
24.74M
1-Year Change
36.49%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $17.56M, a decrease of -83.04%. That is a compound annual growth rate of -30.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 17.56M | -30.49% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
| Dec 11, 2020 | 103.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |